Evofem Biosciences Inc (EVFM)

Evofem Biosciences Inc (EVFM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $980,722; returns 1 day -6.3%.

Evofem Biosciences Inc. (EVFM) is a commercial-stage biopharmaceutical company dedicated to addressing unmet needs in women's sexual and reproductive health. The company generates revenue through the commercialization of two FDA-approved products: Phexxi and SOLOSEC. Phexxi (lactic acid, citric acid, and potassium bitartrate) is a hormone-free, on-demand prescription contraceptive vaginal gel.

Groups EVFM belongs to

• Women's Health
• Healthcare
• Commercial Stage Biotech
• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• Commercial Stage
• Life Sciences
• Unmet Medical Needs

EVFM financial model: income statement, cash flow and balance sheet